Literature DB >> 6296704

Evidence supporting the existence of presynaptic alpha-adrenoceptors in the regulation of endogenous noradrenaline release upon hepatic sympathetic nerve stimulation in the dog liver in vivo.

N Yamaguchi.   

Abstract

The existence and functional significance of presynaptic alpha-adrenoceptors within the liver was investigated in anesthetized dogs. The stimulation-evoked endogenous catecholamine overflow was determined in hepatic venous blood upon hepatic nerve stimulation (12 V, 1-8 Hz, 1 min). Under resting conditions, average plasma catecholamine levels in hepatic venous and aortic blood were 0.064 ng/ml and 0.334 ng/ml, respectively. A frequency-dependent increase (P less than 0.001) was found in the hepatic venous catecholamine overflow, while aortic catecholamine levels did not change significantly at any stimulation frequency tested. The increases in catecholamine overflow were associated with decreases in hepatic arterial vascular conductance (35-66%, P less than 0.001) at all frequencies tested. Yohimbine (0.3 mg/kg, i.v.) potentiated the catecholamine overflow by 110-140% (P less than 0.05) upon stimulation at low frequencies (1-4 Hz). Clonidine (20 micrograms/kg, i.v.) inhibited the catecholamine overflow by 55-76% (P less than 0.05) at frequencies of 1 and 2 Hz, and reduced the hepatic arterial response by 46% (P less than 0.01) at 1 Hz. The pretreatment with yohimbine (0.1 mg/kg, i.v.) abolished the inhibitory effects of clonidine both on the catecholamine overflow and the hepatic arterial responses. The results support the existence of a negative feedback mechanism mediated by presynaptic alpha-adrenoceptors in the local regulation of noradrenaline release from hepatic sympathetic fibers. A functional significance of this process was suggested by an improved correlation found in the presence of clonidine between the catecholamine overflow and the hepatic arterial vascular conductance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6296704     DOI: 10.1007/bf00505482

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  Preferential blockade of presynaptic alpha-adrenoceptors by yohimbine.

Authors:  K Starke; E Borowski; T Endo
Journal:  Eur J Pharmacol       Date:  1975-12       Impact factor: 4.432

2.  Simultaneous estimation of hepatic and portal blood flows by an indicator dilution technique.

Authors:  P M Huet; P Lavoie; A Viallet
Journal:  J Lab Clin Med       Date:  1973-11

3.  The microcirculatory hepatic unit.

Authors:  A M Rappaport
Journal:  Microvasc Res       Date:  1973-09       Impact factor: 3.514

Review 4.  Hepatic vascular bed.

Authors:  C V Greenway; R D Stark
Journal:  Physiol Rev       Date:  1971-01       Impact factor: 37.312

5.  On the monaminergic innervation of the liver.

Authors:  G Ungváry; T Donáth
Journal:  Acta Anat (Basel)       Date:  1969

6.  Hepatic blood flow measurement III. Total hepatic blood flow measured by ICG clearance and electromagnetic flowmeters in a canine septic shock model.

Authors:  J L Nxumalo; M Teranaka; W G Schenk
Journal:  Ann Surg       Date:  1978-03       Impact factor: 12.969

7.  Correlations between hemodynamic parameters of the liver and norepinephrine release upon hepatic nerve stimulation in the dog.

Authors:  N Yamaguchi; D Garceau
Journal:  Can J Physiol Pharmacol       Date:  1980-11       Impact factor: 2.273

8.  Circulating catecholamine levels in human and experimental hypertension.

Authors:  J de Champlain; L Farley; D Cousineau; M R van Ameringen
Journal:  Circ Res       Date:  1976-02       Impact factor: 17.367

9.  Effects of clonidine on canine cardiac neuroeffector structures controlling heart rate.

Authors:  I Cavero; A G Roach
Journal:  Br J Pharmacol       Date:  1980-10       Impact factor: 8.739

10.  Pre- and postsynaptic alpha adrenoceptor selectivity studies with yohimbine and its two diastereoisomers rauwolscine and corynanthine in the anesthetized dog.

Authors:  N B Shepperson; N Duval; R Massingham; S Z Langer
Journal:  J Pharmacol Exp Ther       Date:  1981-11       Impact factor: 4.030

View more
  2 in total

1.  Yohimbine bioavailability in humans.

Authors:  S K Guthrie; M Hariharan; L J Grunhaus
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Peripheral presynaptic and central effects of clonidine, yohimbine and rauwolscine on the sympathetic nervous system in rabbits.

Authors:  B Szabo; L Hedler; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.